Biocon's Q2 preview highlights strong biosimilar growth, while generics face challenges amid mixed sector performance ahead of November 11 results.

Analysts remain bullish on Vedanta Ltd, citing strong earnings potential and strategic positioning amid a recovering ...

In the office supplies industry, you’re not really competing on products. Sure, one brand's printer ink might last a few pages longer, and some pens feel ...

Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for ...